Can fetal heart scans predict risk in growth restriction?
NCT ID NCT07760194
First seen Aug 12, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study looks at whether measuring the heart's pumping and relaxing ability in fetuses with growth restriction can signal how well they are doing. Researchers will use a special ultrasound technique to assess heart function in pregnant women after 28 weeks. The goal is to see if these heart measurements can help predict which fetuses may have worse outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Fetal echocardiography (Doppler ultrasound to measure cardiac function)
- What this could lead to
- If successful, this could help doctors identify which growth-restricted fetuses are at higher risk, potentially guiding earlier interventions and better monitoring.
- What could go wrong
- This is a small, early observational study, so findings may not apply broadly. The heart measurements are technical and may not reliably predict outcomes in all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 28 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Fetuses with IUGR will be included in group 1. Fetuses with normal growth will be included in group 2.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * pregnant women * more than 28 weehs gestation Exclusion Criteria: * intrauterine fetal death
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fetal growth restriction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Women's Health Hospital
RECRUITINGAsyut, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple ultrasound spot hidden heart strain in Growth-Restricted pregnancies?
- Ultrasound may predict hidden placental problems before delivery
- Placental protein clues may unlock mystery of poor fetal growth
- New doppler study aims to spot fetal distress earlier in Growth-Restricted pregnancies
- New ultrasound technique could unlock secrets of placental health in pregnancy
- New screening method could spot pregnancy risks earlier